- Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
- Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
- Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
Key statistics
On Friday, Spruce Biosciences Inc (SPRB:NSQ) closed at 0.7004, 3.21% above its 52-week low of 0.6786, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.70 |
---|---|
High | 0.7112 |
Low | 0.6873 |
Bid | 0.6751 |
Offer | 0.7003 |
Previous close | 0.701 |
Average volume | 672.08k |
---|---|
Shares outstanding | 41.15m |
Free float | 36.37m |
P/E (TTM) | -- |
Market cap | 28.85m USD |
EPS (TTM) | -1.26 USD |
Data delayed at least 15 minutes, as of Apr 19 2024 21:00 BST.
More ▼